{"id":"NCT00171210","sponsor":"Novartis Pharmaceuticals","briefTitle":"An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload","officialTitle":"An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670)in β-thalassemia Patients With Transfusional Iron Overload","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-10","primaryCompletion":"2008-04","completion":null,"firstPosted":"2005-09-15","resultsPosted":"2011-05-02","lastUpdate":"2011-05-30"},"enrollment":506,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Transfusional Iron Overload in β-thalassemia"],"interventions":[{"type":"DRUG","name":"Deferasirox","otherNames":[]}],"arms":[{"label":"Deferasirox","type":"EXPERIMENTAL"}],"summary":"A 1-year randomized Phase III core trial (NCT00061750) using deferoxamine as the comparator was conducted to investigate the efficacy of deferasirox in regularly transfused patients with β-thalassemia 2 years of age and older. Patients who successfully completed this main trial may continue in this extension trial to receive chelation therapy with deferasirox for an additional 4 years.\n\nThe objective of this study is to assess the efficacy and long-term safety of deferasirox in regularly transfused patients with β-thalassemia 2 years of age and older.","primaryOutcome":{"measure":"Long Term Safety and Tolerability Profile of ICL670 Based on the Number of Participants Who Experienced Any Adverse Event","timeFrame":"up to 5 years","effectByArm":[{"arm":"Crossover","deltaMin":109,"sd":null},{"arm":"ICL670","deltaMin":113,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":49,"countries":["United States","Argentina","Belgium","Brazil","Canada","France","Germany","Greece","Italy","Tunisia","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["21628399"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":102,"n":296},"commonTop":["Pyrexia","Cough","Headache","Diarrhoea","Influenza"]}}